Pharma image hit by Seroxat scare

Eighty-six per cent of the public think the reputation of the pharma industry has been damaged by GlaxoSmith­Kline’s delay in coming clean about its Seroxat drug, a PRWeek poll has found.

No Responses to “Pharma image hit by Seroxat scare”

Post a Comment